Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
71.31
+1.78 (2.56%)
At close: May 16, 2025, 4:00 PM
70.00
-1.31 (-1.84%)
After-hours: May 16, 2025, 7:45 PM EDT
Verona Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 401.42 | 399.76 | 271.77 | 227.83 | 148.38 | 187.99 | Upgrade
|
| Cash & Short-Term Investments | 401.42 | 399.76 | 271.77 | 227.83 | 148.38 | 187.99 | Upgrade
|
| Cash Growth | 57.49% | 47.09% | 19.29% | 53.54% | -21.07% | 360.66% | Upgrade
|
| Accounts Receivable | 62.16 | 31.5 | - | - | - | - | Upgrade
|
| Other Receivables | 5.94 | 5.76 | 10.95 | 9.28 | 15.58 | 8.26 | Upgrade
|
| Receivables | 68.09 | 37.26 | 10.95 | 9.28 | 15.58 | 8.26 | Upgrade
|
| Inventory | 7.24 | 6.25 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 11.32 | 7.57 | 3.62 | 2.5 | 4.04 | 4.54 | Upgrade
|
| Other Current Assets | 12.96 | 2.74 | 3.37 | 3.39 | 2.06 | 1.72 | Upgrade
|
| Total Current Assets | 501.03 | 453.57 | 289.71 | 243 | 170.06 | 202.5 | Upgrade
|
| Property, Plant & Equipment | 2.86 | 3.15 | 2.87 | 0.93 | 0.98 | 1.16 | Upgrade
|
| Long-Term Investments | 15 | 15 | 15 | 15 | 15 | - | Upgrade
|
| Goodwill | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | Upgrade
|
| Other Long-Term Assets | 6.51 | 1.97 | - | - | - | - | Upgrade
|
| Total Assets | 525.94 | 474.24 | 308.12 | 259.47 | 186.59 | 204.21 | Upgrade
|
| Accounts Payable | 9.08 | 11.27 | 3.49 | 2.91 | 10.04 | 0.18 | Upgrade
|
| Accrued Expenses | 36.82 | 17.86 | 3.59 | 13.75 | 22.26 | 10.86 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.69 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.08 | 1.12 | 1.18 | 0.68 | 0.65 | 0.8 | Upgrade
|
| Current Income Taxes Payable | 8.89 | 8.89 | - | 0.28 | 0.15 | - | Upgrade
|
| Other Current Liabilities | 0.68 | 2.86 | 0.44 | 1.41 | 0.33 | 2.36 | Upgrade
|
| Total Current Liabilities | 56.54 | 42.68 | 8.69 | 19.03 | 33.42 | 14.2 | Upgrade
|
| Long-Term Debt | 241.74 | 225.76 | 48.37 | 9.77 | 4.87 | 4.64 | Upgrade
|
| Long-Term Leases | 1.06 | 1.24 | 1.78 | 0.21 | 0.29 | 0.51 | Upgrade
|
| Total Liabilities | 299.34 | 269.68 | 58.84 | 29 | 38.58 | 19.35 | Upgrade
|
| Common Stock | 45.02 | 45.02 | 42.77 | 40.53 | 31.86 | 31.79 | Upgrade
|
| Additional Paid-In Capital | 766.37 | 728.2 | 601.06 | 529.19 | 385.07 | 366.41 | Upgrade
|
| Retained Earnings | -578.79 | -562.4 | -388.43 | -333.1 | -263.72 | -207.05 | Upgrade
|
| Treasury Stock | -1.4 | -1.66 | -1.52 | -1.55 | -0.6 | -1.7 | Upgrade
|
| Comprehensive Income & Other | -4.6 | -4.6 | -4.6 | -4.6 | -4.6 | -4.6 | Upgrade
|
| Shareholders' Equity | 226.6 | 204.56 | 249.28 | 230.47 | 148.01 | 184.85 | Upgrade
|
| Total Liabilities & Equity | 525.94 | 474.24 | 308.12 | 259.47 | 186.59 | 204.21 | Upgrade
|
| Total Debt | 243.88 | 228.81 | 51.33 | 10.65 | 5.81 | 5.95 | Upgrade
|
| Net Cash (Debt) | 157.54 | 170.95 | 220.44 | 217.18 | 142.57 | 182.04 | Upgrade
|
| Net Cash Growth | -22.63% | -22.45% | 1.50% | 52.33% | -21.68% | 360.33% | Upgrade
|
| Net Cash Per Share | 1.91 | 2.10 | 2.78 | 3.28 | 2.41 | 5.54 | Upgrade
|
| Filing Date Shares Outstanding | 91.14 | 84.98 | 86.83 | 78.99 | 60.37 | 57.93 | Upgrade
|
| Total Common Shares Outstanding | 91.14 | 84.63 | 80.44 | 75.79 | 60.01 | 57.91 | Upgrade
|
| Working Capital | 444.48 | 410.89 | 281.02 | 223.97 | 136.64 | 188.3 | Upgrade
|
| Book Value Per Share | 2.49 | 2.42 | 3.10 | 3.04 | 2.47 | 3.19 | Upgrade
|
| Tangible Book Value | 226.05 | 204.01 | 248.74 | 229.92 | 147.46 | 184.31 | Upgrade
|
| Tangible Book Value Per Share | 2.48 | 2.41 | 3.09 | 3.03 | 2.46 | 3.18 | Upgrade
|
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.